Bloomberg: Arthur Hayes has recently made a significant investment in a longevity company and has been receiving regular stem cell intravenous infusion treatments over the past year

ChainCatcher news, according to Bloomberg, BitMEX co-founder Arthur Hayes is shifting his investment focus to the field of human longevity. He has recently made a significant investment in a stem cell company that has clinics in Mexico and Bangkok, and has joined its board of directors.

Over the past year, he has regularly traveled to receive intravenous infusion treatments, stating that he "hopes to extend his life as healthily as possible." Although the company name has not been disclosed due to rebranding, he emphasized: this is the trend of the future—more and more countries are relaxing regulations on the use of stem cells.